Receptors and Receptor Heteromers in Atherosclerosis
Year: 2026
Type: article
Abstract: Atherosclerosis, a chronic inflammatory disease characterised by plaque formation in the arterial wall, remains a leading cause of cardiovascular morbidity and mortality. It is a complex disease, underscored by myriad receptors and receptor-mediated processes that collectively regulate inflammation, cell survival, and plaque formation and stability. Of interest are receptor heteromers—macromolecular complexes made of two or more distinct receptor units (protomers). Receptor heteromers composed of G protein-coupled receptors (GPCRs) have received particular interest, due to their broad physiological and clinical relevance. Interestingly, emerging evidence suggests that GPCRs may also form receptor heteromers with receptors from other families, such as the receptor tyrosine kinases and scavenger receptors. This review outlines the roles of receptors and receptor heteromers across atherosclerosis pathogenesis and appraises the evidence for proposed complexes against established criteria for heteromer identification. Heteromer-specific properties are demonstrated for several receptor pairs relevant to lesion initiation and inflammatory amplification, whereas evidence pertaining to advanced plaque processes remains largely inferential. Answering the question of where such receptor heteromers form, and with what functional consequences, is an important prerequisite for evaluating these complexes as therapeutic targets in atherosclerotic cardiovascular disease.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
Funder: Australian Research Council
OpenAlex ID: W7236096070
